Efficacy Results from a 12-month Double-blind Randomized Trial of Arimoclomol for Treatment of Niemann Pick Disease Type C – Presenting an Improved 4-Domain NPC Clinical Severity Scale September 5, 2024
Arimoclomol in adults with NPC in a real-world setting: Long-term data from an expanded access program in the USA April 15, 2024
News
Careers
Contacts
